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he ACA was designed to achieve three primary
goals (1) expand health care coverage, (2) reform
the delivery system, and (3) shift the health care
system to focus on wellness and prevention. These goals
would be achieved through a new regulatory structure
which I call the new governing architecture. The new
governing architecture (NGA) is composed of national
strategies, boards, councils, commissions, and new
departments within the U.S. Department of Health
and Human Services that I have selected based on the
right to health features identified in a 2008 report by
the Special Rapporteur for Health, Paul Hunt. The
components of the NGA attempt to achieve the follow
ing goals: (1) improve the quality of care delivered by
the health care system; 1 (2) shift the system to focus on
prevention and public health; 2 (3) improve the pub
lic insurance programs that are designed to improve
the health of vulnerable populations; (4) create better
federal oversight of private insurance companies; (5)
address the development of an adequate and appropri
ate health care workforce; and (6) collect and monitor
key population health indicators. There are nine compo
nents of the NGA: (a) the National Strategy for Quality
Improvement in Health Care, (b) the National Preven
tion, Health Promotion and Public Health Council and
Advisory Council, (c) the National Prevention, Health
Promotion, Public Health, and Integrative Health Care
Strategy, (d) the Independent Payment Advisory Board,
(e) the Center for Medicare and Medicaid Innovation,
(f) the CMS - Federal Coordinated Healthcare Office,
(g) the CMS - Center for Consumer Information and
Insurance Oversight, (h) the Health Care Workforce
Commission, and (i) the Commission on Key National
Indicators. This article will only address two compo
nents of the NGA that help to reform the delivery of
health care and to control costs of the health care sys
tem: the Center for Medicare and Medicaid Innova
tion (CMMI) and the Independent Payment Advisory
Board (IPAB). The republican-controlled federal gov
ernment has partially disassembled these two compo
nents, threatening the effectiveness of federal delivery
system reform and cost control initiatives.
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The results of the 2016 election meant there will
be changes to the ACA and by implication to the new
governing architecture. Presidential candidate Don
ald Trump did not provide a detailed health care
policy agenda, so the health care industry and indi
vidual states were forced to discern the meaning of
a campaign promise to "repeal Obamacare." Article
I, Section 1 of the U. S. Constitution vests "all legis
lative powers" in Congress. According to the House
Republican Leadership whitepaper, A Better Way, the
values that will govern their health care reform pro
posals include: choice, portability, innovation, and
transparency. 3 These same values were also reflected
in the numerous health care reform bills introduced
in 2017, like the American Health Care Act, the Better
Care Reconciliation Act, the Obamacare Repeal and
Reconciliation Act of 2017, the Health Care Freedom
Act, and Graham-Cassidy, Heller-Johnson.

A. CMMI's Viability Under a Republican
Controlled Federal Government
CMMI was created in 2010 to test new payment and
delivery models that reduce health care costs and
improve the quality of care provided in Medicare,
Medicaid, and the Children's Health Insurance Pro
gram. In 2017, the viability of CMMI was in ques
tion. Legislative proposals like Better Way, recom
mended that CMMI be repealed effective January 1,
2020, the date the center would run out of its initial
10-year funding of $10 billion dollars. 4 There was also
the possibility that CMMI's budget would be reduced,
or that its authority to require participation in man
datory models would be limited. 5 On September 29,
2016, several republican congressmen, wrote to Act
ing CMS Administrator Andrew Slavitt expressing
concern that CMMI mandated participation in some
models (i.e. bundled payment). 6 President Trump's
first HHS Secretary, Tom Price was one ofthe authors.
The congressmen recommended limiting the size
and scale of participation in models.7 They criticized
CMMI for exceeding its statutory authority by man
dating participation. Participation in most of CMMI's
demonstration projects has been voluntary. 8 However,
to ensure that participation was sufficient to produce
reliable statistical results and to accomplish previous
HHS Secretary Burwell's goals to shift to alternative
payment models in Medicare, experts recommended
that participation be mandatory.9 Moreover, under the
enabling language creating CMMI, Section 3021 (a) of
the ACA, the Secretary of HHS has broad authority in
designing payment models. 10
Shifting to a value-based reimbursement policy is
a way to lower U.S. health care costs and to reform
health care-delivery with broad bipartisan support.
858

On December 6, 2016, the Health Care Transfor
mation Task Force (HCTTF) wrote to the incoming
President and Vice-President, the HHS Secretary
nominee, the CMS Administrator nominee, and Con
gressional leadership on the important work that
CMMI was conducting.11 The task force is composed
of 43 members, including employers, payers, insur
ance companies, health care providers and consum
ers/patients. The members include 6 of the top 15
health systems in the United States and 4 of the top
25 insurance companies. Elliot Fisher (Director of
the Dartmouth Institute for Health Policy) and Mark
McClellan (former CMS Administrator and FDA
Commissioner under George W. Bush) are members.
The task force is working to promote the transition to
value-based payments. HCTFF members have a goal
to transition 75% oftheir business to value-based pay
ment models by 2020. When the letter was written,
the members had reached 41 % of their goals, using
capitation, global payment, ACOs, clinical episode,
and oncology care value-based models.
The HCTTF letter emphasized the positive impact
of CMMI on private sector delivery system reform ini
tiatives. The letter noted that CMMI was an "effective
laboratory to test a variety of value-based care mod
els" and an "important partner for the private sector to
push broad scale reform:' CMMI served as a mecha
nism for the private sector to provide "direct feedback
to improve government programs and operations."
Moreover, CMMI supported state-based models that
would allow states to innovate and drive the local mar
ket to adopt payment reforms and value-based care. 12
The HCTTF made two recommendations to the
Republican administration: (1) continue CMMI or a
comparable entity, and (2) send a signal of support
for value-based payments that lower costs, improve
quality, and focus on patient needs. According to
HCTTF, using value-based payments to align the
public and private sectors is the single policy initia
tive that holds the most "promise to moderate entitle
ment spending:'13

(i) CMMI Facilitates Reformation ofState
Health Care Delivery Systems - Maryland and
Massachusetts
CMMI's authorizing legislation 14 and development of
State Innovation Models (SIM) recognize the role of
states in implementing delivery system reform initia
tives designed to lower health care costs and improve
quality. CMMI recognizes the importance of states
in "determining the effectiveness of the health care
system and the health of their population." 15 States
impact health as "payers for Medicaid, the Children's
Health Insurance Program, and state employee popuJOURNAL OF LAW, MEDICINE & ETHICS
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lations, and they impact care delivery through their
licensing and public health activities." CMMI devel
oped State Innovation Models (SIM) "to address
specific issues in [a] state" and to "accelerate [com
prehensive] state-level health care transformation:'16
Grant awards were made to develop State Health
Care Innovation Plans (Model Design awards) and to
fund implementation of transformation plans (Model
Test states). Since 2013, CMMI has provided SIM
funding to 34 states, 3 territories and the District of
Columbia. Unlike other CMMI models that test a spe
cific delivery system or payment model, SIM models
focus on "developing the infrastructure necessary to
enhance coordination and communication across the
care continuum." These models are important to fed
eral-state efforts to control health care costs because
CMMI partners with other CMS entities and other
HHS agencies to "align and leverage federal delivery
system reform programs and opportunities:'11 Mary
land will use the grant it received under CMMI's
State Innovation Model to implement a component
of the next phase of the All Payer Model (Total Cost of
Care). Initially from 2016 - 2018, Maryland worked
on developing a Dual Eligible ACO for its Medicaid
program to implement in 2019. 18 Under the July 2018
Total Cost of Care Agreement, the state will continue
to progressively plan for and implement dual eligible
clinical care and payment alignment. The state will
begin with integrating behavioral health and Medic
aid providers into the Maryland Primary Care pro
gram and consider at a later time the national dual
eligible ACO model or another national Medicare/
Medicaid model.19 Similarly, Massachusetts received
a SIM Model Test Grant in April 2013 that was
extended. 20 Massachusetts Medicaid initially estab
lished a patient-centered medical home model, Pri
mary Care Payment Reform Initiative (PCPRI), that
provided capitated payment and a coordination fee.
It developed certified Community Partners, which
are community-based organizations with expertise
in delivering care to members with behavioral health,
long term support, and social services. While provid
ers lauded the timely access to behavioral services,
initially neither utilization nor spending decreased
and there were no significant changes in measures
of care coordination or quality of care. Thus in 2017,
Massachusetts received a Medicaid Section 1115
waiver (2017-2022) to implement accountable care
models that continue the work ofthe PCPRI, expands
use of the state health-information-exchange to share
information among clinicians, and continues use of
e-referrals to community services.
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(ii) CMMI's New Direction - New CMS
Administrator C9 DeputyAdministratorfor
Innovation C9 Quality and Director ofCMMI
In September 2017, CMS Administrator Seema
Verma articulated 6 goals for CMMI. Those goals
are (1) Choice and competition, (2) Provider choice
and incentives, (3) Patient-centered care, (4) Benefit
design and price transparency (use of data to ensure
receipt of cost-effective care that improves outcomes),
(5) Transparent model design and evaluation (use
partnerships and collaborations with public stake
holders and gather ideas from a broad array of organi
zations), and (6) Small Scale Testing. 21 The request for
information (RFI) sets forth eight areas of focus for
future models. 22 The one that would directly impact
Maryland and Massachusetts's existing global budget
initiatives include the state-based and local innova
tion, including Medicaid-focused models. While the
RFI asserts that the agency is going in a new direction,
the primary thrust of this area is similar - allowing
states and health care providers to work with CMS
to drive reform and local innovation that "meets the
needs and goals of each state for improving care and
lowering costs:'
More clarity as to the direction of HHS came from
the appointment of the second Trump Secretary
for HHS, Alex Azur on January 24, 2018. In March
2018, he identified value-based transformation of the
health care system as one of his top four priorities. He
acknowledged that this important concept is more
than a decade old. The four key factors to achieve this
transformation are having interoperable health infor
mation technology; transparent health care prices; a
willingness to experiment with new, flexibly-designed
models of care delivery, and the removal of govern
ment burdens that impede value-based transforma
tion. In April 2018, Secretary Azur appointed Adam
Boehler the Director of CMMI.

B. IPAB Under the Republican
Administration

2018

The Journal ofLaw. Medicine ef Ethics. 46 (2018): 857-861. © 2018 The Author(s)

IPAB was created to develop proposals to slow the
growth of Medicare costs if they are projected to
exceed a specified target. 23 This is the most contro
versial and vulnerable feature of the new governing
architecture. No presidential appointments were
made, and a lawsuit was filed challenging its con
stitutionality. 24 Better Way recommended repeal
ing IPAB. 25 The whitepaper recommends allowing
elected officials to reform the program using tools
that lower costs and improve quality by allowing
health plans and providers to compete for the busi
ness of Medicare seniors. 26
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(i) Congressional Legislation - 2017
Federal legislation reflects a continued effort to elimi
nate IPAB that is consistent with the recommenda
tion in Better Way. In early February 2017, the Sen
ate and the House of Representatives introduced bills
to abolish IPAB. 27 However, Congress was unable to
pass a bill or joint resolution by the three-fifths major
ity required under the ACA. Instead, in September
of 2017, the Senate passed a budget bill that would
defund IPAB. 28 While the House of Representatives
passed H.R. 849 to repeal IPAB on November 2, 2017,
the Senate did not pass a companion bill. 29 Finally, on
February 9, 2018, IPAB was repealed by the Biparti
san Budget Act of 2018. 30

trol systems. 34 Maryland has successfully limited its
per capita hospital revenue growth for all payers to
less than the state GDP (3.58%): 2014 (1.47%), 2015
(2.31 %), 2016 (.80%), and 2017 (3.54%). 35 On January
1, 2019, Maryland will shift from an All-Payer system
focused on controlling hospital costs for the Medicare
program to a Total Cost of Care program that focuses
on limiting health care costs by all providers for the
entire health care system. 36 Over ten years Maryland
will continue to keep its health care costs below the
state GDP, limit its Medicare per beneficiary spend
ing growth to save the Medicare program at least $1
billion dollars by 2023, and improve patient outcomes
and quality of care. 37 In contrast, Massachusetts has

(ii) IPAB Repeal -Loss ofthe Federal Oversight
Entity While State Oversight Continues
The Congressional Budget Office (CBO) originally
projected that IPAB would achieve Medicare sav
ings of $15.5 billion from 2015 until 2019. 31 A simi
lar amount of savings, $15 billion, would occur from
2018-2027. As expected, repealing IPAB is projected
to increase the federal deficit by $17.5 billion over ten
years (2018-2027). 32
During IPAB's tenure, the chief actuary first pre
dicted that Medicare's growth rate would exceed the
target rate in 2017. Thereafter, there were predictions
for 2022, and more recently 2024, 2025, and 2026. 33
Fortunately, the Medicare program did not exceed its
per capita growth rate in 2017.
In contrast to the federal move away from an over
sight agency, states continue to use oversight agencies
to contain health care costs and reform their delivery
systems. For example, both Maryland and Massa
chusetts are continuing their efforts to bend the cost
curve by limiting their health care cost growth to their
state GDP through comprehensive or global cost con-

had mixed results controlling its health care costs.
The total health care expenditure was below the state
benchmark of 3.6% for 2013 (2.4%). It increased in
2014 (4.25 %) and 2015 (4.8%), and is preliminarily
below the benchmark for 2016 (2.8%). However, the
four-year average is below the state benchmark and
each year's growth is below the national growth rate. 38
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Conclusion
The cost control components of the AC.A's new gov
erning architecture have been partially disassembled
by the Republican controlled federal government.
IPAB, the federal oversight entity, was finally repealed
in 2018. CMMI is the remaining backstop to con
trol federal health care costs and redesign the U.S.
health care system. For 13 months CMMI's value was
questioned. The new direction for HHS and CMMI
reflects a deregulatory, flexible focus. The rescission of
the mandatory Episode Payment Models, the Cardiac
Rehabilitation Incentive Payment Model, and regula
tions39 exemplifies this shift. Moving forward collabor-
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ative governance and state-based initiatives will drive
future delivery system reform and cost control efforts.
Note
The author has no conflicts to disclose.
19.
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